Dr Lim Si Jing Joline - Medical Oncology

Dr Lim Si Jing Joline

Medical Oncologist

Medical Reviewer

Specialty

Medical Oncology

Languages

Cantonese, English, Hokkien, Mandarin

Gender

Female

Insurance Panel

Great Eastern, Income, Prudential^, Singlife

Please check with your insurance provider for more information, and for their most up-to-date list of panel doctors.

^Specialists may qualify to be on the Extended Panel (EP). You may enjoy selected panel benefits depending on your policy and riders.

Make an appointment

Experience

Associated treatments

  • Abdominal paracentesis
  • Lumbar Puncture
  • Preparation and Administration of Chemotherapy

Research & publications

Turner, N., Saura, C., Aftimos, P., Van Den Tweel, E., Oesterholt, M., Koper, N., Colleoni, M., Kaczmarek, E., Punie, K., Song, X., Armstrong, A., Bianchi, G., Stradella, A., Ladoire, S., Lim, J. S. J., Quenel-Tueux, N., Tan, T. J., Escrivá-De-Romaní, S., O’Shaughnessy, J., . . . Klint, L. (2024). Trastuzumab duocarmazine in pretreated human epidermal growth factor receptor 2–Positive advanced or metastatic breast cancer: an Open-Label, Randomized, Phase III trial (TULIP). Journal of Clinical Oncology.

Lim, J. S., Wong, A. L., Ow, S. G., Ngoi, N. Y., Chan, G. H., Ang, Y. L., Chong, W. Q., Lim, S. E., Lim, Y. W., Lee, M., Choo, J. R., Tan, H. L., Yong, W. P., Soo, R. A., Tan, D. S., Chee, C. E., Sundar, R., Yadav, K., Jain, S., . . . Lee, S. (2022). Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer. Clinical Cancer Research, 28(11), 2248–2256.

Pascual, J., Lim, J. S. J., Macpherson, I. R., Armstrong, A. C., Ring, A., Okines, A. F. C., Cutts, R. J., Herrera-Abreu, M. T., Garcia-Murillas, I., Pearson, A., Hrebien, S., Gevensleben, H., Proszek, P. Z., Hubank, M., Hills, M., King, J., Parmar, M., Prout, T., Finneran, L., Malia, J., … Turner, N. C. (2021). Triplet Therapy with Palbociclib, Taselisib, and Fulvestrant in PIK3CA-Mutant Breast Cancer and Doublet Palbociclib and Taselisib in Pathway-Mutant Solid Cancers. Cancer Discovery, 11(1), 92–107.

Yong, K. J., Gao, C., Lim, J. S., Yan, B., Yang, H., Dimitrov, T., Kawasaki, A., Ong, C. W., Wong, K., Lee, S., Ravikumar, S., Srivastava, S., Tian, X., Poon, R. T., Fan, S. T., Luk, J. M., Dan, Y. Y., Salto-Tellez, M., Chai, L., & Tenen, D. G. (2013). Oncofetal GeneSALL4in aggressive hepatocellular carcinoma. New England Journal of Medicine, 368(24), 2266–2276. 

Contact Our Call Centre

Parkway Support Centre

Clinic

Curie Oncology & Haematology

3 Mount Elizabeth #11-12
Mount Elizabeth Medical Centre
SG 228510
6970 8186
6970 8156

Curie Oncology (Gleneagles)

6 Napier Rd #08-15/16
Gleneagles Medical Centre
SG 258499
6908 6315
6908 6316

Curie Oncology

38 Irrawaddy Road #08-21/29/30
Mount Elizabeth Novena Specialist Centre
SG 329563
6259 5368 & 6592 8616